Qube Research & Technologies LTD Syndax Pharmaceuticals Inc Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 297,303 shares of SNDX stock, worth $5.54 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
297,303
Previous 93,889
216.65%
Holding current value
$5.54 Million
Previous $2.23 Million
173.19%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SNDX
# of Institutions
202Shares Held
87.1MCall Options Held
268KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$147 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$137 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.72MShares$107 Million9.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$89.4 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$72.4 Million1.09% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.05B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...